A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection GAITHERSBURG, Md., July 09, 2026 (GLOBE NEWSWIRE) -- 20/20 ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results